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Abstract
Background—Although there is concern that food allergic reactions may negatively affect the 
natural history of food allergy, the impact of reactions on food-specific IgE (sIgE) or skin prick 
tests is unknown.
Objective—To measure the effects of allergic reactions on SPT wheal size and sIgE 
concentrations to milk, egg and peanut.
Methods—Participants included 512 infants with likely milk or egg allergy enrolled in a multi-
center observational study. Changes in sIgE and SPT to milk, egg, and peanut were measured 
before and after oral food challenge (OFC) or accidental exposure for 377 participants.
Results—Median age of the cohort at time of analysis was 8.5 years (67% male). There were no 
statistically significant changes in sIgE or SPT after positive OFC to milk, egg, or peanut 
(n=20-27 for each food). Change in sIgE and SPT was measured after 446 and 453 accidental 
exposure reactions, respectively. Median change in sIgE decreased by 0.33 kUA/L (p<.01) after 
milk and by 0.34 (p<.01) after egg reactions; but no other statistically significant changes in sIgE 
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or SPT were observed for milk, egg, or peanut. Limiting analysis to only participants with 
diagnostic testing done within 6 months of an accidental exposure reaction, peanut SPT increased 
1.75 mm (p<.01), but a significant increase was not noted when all participants with testing done 
within 12 months were considered.
Conclusions—The results suggest that reactions from OFCs and accidental exposure are not 
associated with increases in sensitization among children allergic to milk, egg or peanut.
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INTRODUCTION
Food allergy is an important public health concern affecting up to 8% of children (1). 
Current management strategies require strict avoidance of causal foods and prompt 
treatment of allergic reactions, including treatment with injectable epinephrine for severe 
symptoms (2, 3). Strict dietary avoidance is difficult, and accidental or purposeful exposure 
to causal foods may occur (4). Accidental ingestions occur when an individual unknowingly 
or unintentionally ingests a food containing or contaminated with a food allergen. 
Purposeful (or non-accidental) ingestions occur when an individual knowingly ingests a 
causal food allergen either as the result of non-adherence to dietary instructions or during a 
diagnostic oral food challenge (OFC).
While the acute, potentially life-threatening risk of food allergen exposure is well described 
(3); the long-term impact of accidental or purposeful food allergen exposure on the long 
term prognosis of food allergy is unknown. We previously reported the annualized allergic 
reaction rate due to foods was 0.81 reactions per year among the current study population 
with >70% of participants reporting at least one unsupervised community exposure resulting 
in a food allergy episode (FAE) to a known food allergen over a 3-year period (4). In 
addition to FAEs occurring in the home or community, food allergic children are also 
exposed to food allergens when diagnostic OFCs are conducted for clinical or research 
purposes. The potential impact of these exposures on food-specific IgE (sIgE) 
concentrations and skin prick test (SPT) responses has not been previously reported. The 
consequences of these exposures, specifically the concern the reactions may reduce the 
chances of outgrowing a food allergy, is often questioned by patients, caregivers, and 
clinicians, and could result in deferral of OFCs (5). In previous investigations, seasonal 
environmental aeroallergen exposure has been associated with a rise in both serum allergen-
specific IgE concentrations (6) and increase in skin prick sensitivity (7). It is unclear if a 
similar boosting effect occurs after ingestion of a food allergen. To our knowledge, prior 
studies have not examined changes in sIgE concentrations or SPT size before and after 
exposure to food allergens in a large pediatric cohort. Understanding the impact of 
accidental and/or purposeful food allergen exposure on these indices may inform patients, 
caregivers, and clinicians regarding the potential long-term impact of these exposures on the 
natural course of food allergy.
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The aim of this investigation was to examine the change in sIgE concentration and SPT 
wheal size to milk, egg, and peanut before and following exposure to each respective food 
allergen. The study population consisted of 512 children with milk and/or egg allergy 
enrolled in a multicenter observational study aimed to examine immunologic, genetic, and 
environmental factors affecting the natural course of food allergy (8,9). Participants had 
OFCs when protocol-specified criteria were met and had blood drawn for serum IgE 
concentrations and SPTs performed at regularly scheduled visits. Caregivers reported FAEs 
in “real-time” after an exposure to a food allergen.
METHODS
Subjects
Participant characteristics and study enrollment procedures were previously reported (8,9). 
Briefly, this is an observational study of 512 infants in the Consortium for Food Allergy 
Research observational study (COFAR2) enrolled with likely egg or milk allergy who were 
not yet diagnosed with a likely peanut allergy, recruited at ages 3-15 months, and enrolled at 
5 US sites (New York, NY, Baltimore, MD, Little Rock, AR, Denver, CO, Durham, NC). 
Infants fulfilled at least one of the following 2 criteria: 1) convincing allergic reaction to 
milk and/or egg with a positive prick skin test (SPT) to the trigger food(s), and/or 2) 
moderate to severe atopic dermatitis and a positive SPT to milk and/or egg. Infants were not 
enrolled if they had a confirmed or convincing allergy to peanut. A Data Safety Monitoring 
Board and local Institutional Review Boards approved study procedures, and written 
consents were obtained. Participants were scheduled for a clinical evaluation at 6-month 
intervals for 2 visits, and then yearly, with telephone contacts between each visit.
Inclusion in the current analysis required exposure to milk, egg or peanut during a first oral 
food challenge (OFC) to the individual food, whether or not a reaction occurred, or a first 
allergic reaction, termed a food allergy episode (FAE), after enrollment if tests for 
sensitization were available within a year before and following the exposure or challenge. 
The last enrollment to CoFAR2 was in March 2008; participants are still being followed, 
however, the database for this report was closed on February 12, 2015.
Oral Food Challenges (OFC)
Physician supervised oral food challenges were offered at clinician discretion and family 
preference guided by the protocol under the following circumstances: 1) there was no recent 
(past 6 months) reaction to the food, 2) Current test results (skin test/plasma IgE) indicated 
approximately a 50% or better chance of tolerance (egg, milk IgE < 2 kUA/L, Peanut IgE < 
5 kUA/L if no past history, < 2 kUA/L if positive history) and skin tests wheal < 10 mm. 
After 5 years in the study, OFCs were offered without requiring the aforementioned test 
results. The food challenges were generally performed without masking, and ingestion of a 
meal size amount (1 egg, 2 tablespoons peanut butter, 6-8 ounces of milk) without 
symptoms was considered “passing”. The results in this report focus on the first OFC to 
milk, egg and/or peanut.
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Food Allergic Episodes (FAE)
A structured questionnaire (4) was used to obtain details of allergic reactions related to 
unscheduled exposure to milk, egg or peanut. Participants were requested to contact the 
study site for any allergic reactions, at which time this information was recorded. Subjects 
were also queried about interval allergic reactions at each in-person or telephone encounter. 
Reaction severity was graded based upon Perry et al (10) as mild (skin and/or oral symptoms 
and/or upper respiratory symptoms but not all 3 organ systems); moderate (skin, oral and 
upper respiratory symptoms, or gastrointestinal symptoms); and severe (lower respiratory 
symptoms, cardiovascular symptoms or a combination of skin, oral, upper respiratory and 
gastrointestinal symptoms).
Skin Prick Tests (SPT) and Serum IgE (sIgE)
SPTs were performed using the GreerPick® (Lenoir, NC) with participants avoiding 
antihistamines for at least 5 half-lives of the specific agent. Tests were performed on the 
infant’s back and at 15 minutes the wheal was outlined in pen and transferred by tape to 
paper. The size of the longest diameter and its longest perpendicular were averaged. The 
final SPT wheal size was determined after subtraction of the saline control. Tests were 
considered reliable if the wheal of the negative control (50% glycerin-saline) was 3 mm or 
smaller and wheal size of the histamine control was at least 3 mm larger than the wheal size 
of the negative control. The following extracts were used (Greer catalog number in 
parentheses, Lenoir, NC): cow milk (F293), chicken egg white (F272), and peanut (F171). 
The concentration of specific IgE antibody to egg, milk and peanut were measured from 
plasma at a single central laboratory using the Phadia ImmunoCAP® system (Uppsala, 
Sweden) reported in kUA/L.
Statistics
Summary statistics for demographics are presented whether or not a participant contributed 
to any of the analyses; differences in demographic characteristics for those participants in 
some analyses versus those not in any analyses were conducted using a chi-square test for 
categorical outcomes and a Wilcoxon rank sum test for continuous outcomes. For each of 
the OFC and FAE analyses of change in IgE or SPT, the Wilcoxon signed rank test is used 
to test whether the median change in the score differed from zero. The correlation between 
either the number of days between tests or the number of days after the test and the change 
in IgE or SPT was analyzed using Spearman’s correlation. The association between levels of 
a baseline characteristic or event characteristic and the change in IgE or SPT score is tested 
with the Kruskal-Wallis test; baseline characteristics tested included age at FAE or OFC 
(grouped), race (grouped), ethnicity, clinical site, number of food allergies (milk/egg/peanut, 
grouped if necessary), and AD (grouped if necessary); event characteristics included 
severity of FAE symptoms. Characteristics were tested if a minimum number of participants 
were included in the levels of the characteristic; for some characteristics, if particular levels 
were sparse they were excluded or grouped (e.g., grouping atopic dermatitis as none to mild, 
and moderate to severe). Most factors could not be tested for an association with a positive 
or negative OFC results due to small numbers. Additionally, to explore a subgroup with 
larger changes in SPT/IgE, the association between being in the upper quartile of change 
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score and specified risk factors was analyzed using Fisher’s exact test. The analyses focus 
on the first reported FAE for each of the three allergens or first OFC for each antigen; a 
participant could therefore contribute data to each of the FAE analyses (milk, egg, and/or 
peanut) and each of the OFC analyses. Subsequent FAEs and OFCs to the same food are not 
included in the analyses as restricting data to the first food-specific event removes carry-
over effect from prior events in the same person. A large number of statistical tests were 
conducted for these analyses. Formal adjustments for multiplicity (e.g., Bonferroni or 
Benjamini-Hochberg) were not applied, as this was an exploratory analysis. Instead to help 
control for potentially spurious results, a p-value of <0.01 was used to define significance. 
An alternative exploratory analysis was performed by assuming that categorical changes in 
sIgE levels may be clinically relevant (for example if sIgE increased from <0.35 kUA/L to 
>1 kUA/L, 1-2 kUA/L decreases to <= 0.35 kUA/L, etc.) and these methods are shown in 
the Online Repository, Supplemental Analyses.
RESULTS
Demographic characteristics
Table E1 shows the demographic features of the children who underwent OFCs or 
experienced FAEs included in these analyses, compared to the remainder of the 
observational study cohort. The median months on study is 84.6 (IQR: 75.4 – 90.4) for those 
in the analyses included here compared to 70.0 (IQR: 53.8 – 84.2) months for those not in 
the analyses (p<0.01). The median IgE levels at enrollment for those undergoing OFCs was 
(kUA/L) milk- 0.9 (IQR: 0.2-4.2), egg- 1.4 (IQR: 0.2-5.6), and peanut-0.6 (IQR: 0.0-3.1), 
for those experiencing FAEs was milk-2.1 (IQR: 0.3-9.9), egg- 3.2 (0.7-11.5), and 
peanut-1.7 (0.2-9.8). For those in any of the OFC or FAE analyses, the median IgE levels at 
enrollment were (kUA/L) milk-1.4 (IQR: 0.2-7.3), egg- 2.9 (0.5-10.9), peanut-1.3 (0.1-8.1) 
and for those in the observational cohort but not included in any analysis, it was milk- 0.1 
(IQR: 0.0-1.1), egg- 0.9 (0.1-3.6), and peanut-0.3 (0.0-2.2) (p<0.01 for each). Since OFC 
and FAE analyses are conducted separately for milk, egg, and peanut and separately for 
change in IgE and change in SPT, the actual distribution of participants in each analysis 
varies. At the time of data closure for this report, the overall observational study population 
had a median age of 8.5 years (IQR: 8.2 - 9.0). Among all participants with an OFC or FAE 
in the overall population, the median age (months) of a first OFC was milk 25.5 (IQR: 20.0 - 
40.3), egg 35.3 (IQR: 26.0 - 51.0) and peanut 49.7 (IQR: 43.6 - 66.3), and the median age 
(months) of a first FAE was: milk 17.0 (IQR: 13.1 - 25.8), egg 22.2 (IQR: 15.7 - 38.2) and 
peanut 40.5 (IQR: 20.4 - 62.7).
Oral Food Challenges
Serum food-specific IgE—There were 229 OFCs among 157 participants meeting the 
criteria for the analysis of specific IgE: 82 milk (32% positive), 86 egg (26% positive) and 
61 peanut (36% positive). The median time (days) that serum was obtained pre/post the OFC 
were: milk-70/278, egg- 97/250 and peanut-99/257. Considering positive OFCs only, for 
milk there was a median decrease of 0.10 kUA/L (p=0.13) after the OFC, for egg a median 
decrease of 0.01 kUA/L (p=0.69) and for peanut there was no change (p=0.60) (Figure 1a).
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Skin prick tests—There were 225 OFCs among 153 participants meeting the criteria for 
the analysis of specific SPT results: 83 milk (33% positive), 83 egg (27% positive) and 59 
peanut (34% positive). The median time (days) that skin testing was performed pre/post the 
OFC was milk- 69/272, egg- 92/250 and peanut- 99/262. Among positive OFCs, there were 
no statistically significant changes in skin test size (Figure 1b). Negative OFCs were 
associated with small significant decreases in skin test responses for milk and egg (Figure 1b 
and Table 1), possibly reflecting changes after time ingesting the food.
Food Allergy Episodes
Serum food-specific IgE—There were a total of 446 FAEs meeting analysis criteria 
among 319 participants: 205 milk, 156 egg and 85 peanut. The median time (days) that 
serum was obtained pre/post the FAE was: milk-116/95, egg-138/103 and peanut-177/131. 
There was a median decrease in milk specific IgE of 0.33 kUA/L (p<.01), a decrease in egg 
specific IgE of 0.34 kUA/L (p<.01) and an increase in peanut specific IgE of 0.13 kUA/L 
(p=0.029, NS). Figure 2a shows the change in food specific IgE for the 3 foods. Considering 
demographic and clinical factors, including severity of reactions, there was no association 
with milk or peanut results. For egg, in grouping race as white versus non-white, there was a 
greater decrease among non-white (1.2 kUA/L) than white (0.2 kUA/L, p<.01).
Skin prick tests—There were 453 FAEs meeting the criteria for the analysis of specific 
SPT results among 325 participants: 207 FAEs to milk, 161 to egg and 85 to peanut. The 
median time (days) that skin testing was performed pre/post the FAE was: milk-108/95, 
egg-138/101 and peanut-166/132. Figure 2b shows the SPT results to all 3 foods. There was 
no change in median SPT wheal size for milk (0.0 mm; p=0.55, NS) and a decrease for egg 
(1.0 mm; p=0.09, NS) and increase for peanut (1.5 mm, p=0.02, NS). Considering the 
demographic and clinical factors described previously, none were associated with the 
results.
Results limiting window of time between food exposure and testing—The time 
of testing of SPT or specific IgE testing was dictated by the timing of annual study visits and 
not aligned with OFCs or FAEs. Therefore, there was a wide range of times between events 
and testing, as noted above. It could be hypothesized that changes due to exposure may be 
more evident if tests were done proximate to reactions. We therefore limited analyses to 
events with samples obtained within 6 months or 1 month of an FAE or within 6 months of 
an OFC. Regarding data within 6 months of a positive OFC, there were not more than 7 
OFCs for outcomes except change in SPT after positive milk OFC, which did not have a 
statistically significant difference (data not shown). Data for FAEs are shown in Table 2. 
The data are limited by decreasing numbers of participants when narrower times are 
evaluated. One statistically significant outcome was noted in these restricted time periods: 
peanut SPT increased 1.75 mm (p<.01) when evaluations were limited to testing within 6 
months of an FAE. These results were in the same direction (increase) as results obtained in 
the 1 year time frame. In an additional analysis to explore the association of change scores 
with time, there was no strong correlation (Spearman correlation coefficient less than −0.5 
or greater than 0.5) between the changes in IgE or SPT and either the number of days 
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between each participant’s before and after tests or the number of days after the test, within 
any of the egg, milk, or peanut analyses.
Results of additional exploratory analyses—Additional analyses were conducted to 
specifically assess those children with greater increases in IgE or SPT, focusing on the upper 
quartile of change for association with specified risk factors, to determine if this group had 
identifiable risk factors. For FAE results, no baseline clinical or demographic characteristic 
tested was associated with results in the upper quartile of response for any of the foods. 
There were too few participants in the OFC studies to perform this analysis. The additional, 
alternative analysis using categorical changes in IgE levels support the main conclusions of 
the paper, as reviewed in the Online Repository Supplemental Analyses.
DISCUSSION
The difficulties of elimination diets in the management of food allergy are well established, 
with frequent accidental reactions occurring as a result. For example, we previously reported 
in the full CoFAR observational study cohort an annualized rate of 0.81 accidental reactions 
per year (4). However, the prognostic implications, if any, of such exposures is unknown. 
Similarly, food allergic children are exposed to known food allergens during diagnostic 
OFCs, and the long-term impact of these exposures has not been previously established. The 
question of specific interest in the current study was whether such intermittent exposures 
negatively influence the trajectory of the allergy by intensifying or prolonging allergic 
sensitization. For this reason, and because some of the children entered this study without 
previously documented oral exposure, we focused only on symptomatic exposures, FAEs or 
failed OFCs, in participants who were thus known to be allergic. We report here that there 
were no statistically significant changes in sIgE or SPT following positive OFCs to milk, 
egg or peanut. IgE levels and skin test sizes reflect risk of current allergy.(1-3) The overall 
lack of any significant change in skin test or IgE level from OFC induced reactions suggests 
that there is no change in the reaction risk following the exposure compared to before the 
exposure. The several significant median changes from FAEs for egg and milk were small 
decreases, which should not correlate with any increased risk of reactions. The median 
peanut FAE related increase of 0.13 kUA/L and SPT 1.5 mm is unlikely to reflect significant 
changes in risk.
We hypothesized that there could be factors, such as a more severe reaction, that could 
account for persons having a greater increase in sensitization parameters post-exposure. 
However, when exploratory analysis was performed to determine if there were factors 
associated with those having the highest quartile of change after FAE, none were identified.
Some sensitization parameters showed statistically significant increases. In the case of 
peanut, median serum-specific IgEs and SPTs increased by 1.3 kUA/L (p=0.02 NS) and 1.75 
mm (p<0.01), respectively, in participants who were assessed within six months of the 
symptomatic FAE. However, the decrease in observed difference and lack of a detectable 
change at the 0.01 level in these parameters when including participants measured up to one 
year after the FAE suggests that this small upward deflection is ultimately inconsequential. 
In contrast to peanut, egg and milk sensitization parameters showed small, post exposure 
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decreases. The reason for this difference in direction of change is unknown, and could be 
related to adjuvant or other effects, but ultimately all changes in sensitization were small and 
presumably clinically insignificant or overall not elevated up to one year following 
exposure.
Because this cohort was not specifically designed a priori to answer the research question at 
hand, the protocol did not standardize the collection of skin or serum outcome variables in 
relation to planned or accidental exposures. Instead, these parameters were measured at 
fixed intervals related to time of study enrollment. As a result, the intervals between 
exposures and the measurements of sensitization were not uniform among participants and 
the data are somewhat limited by the necessarily post hoc approach to the analysis. It 
remains possible that the observed heterogeneity with respect to timing of measurements 
could lead to an imprecision of the effects of exposures on the outcome variables. However, 
it can be reasonably concluded that (1) the variation occurs randomly; and, (2) when viewed 
across the study population, the average long-term effects are minimal. Importantly, the 
severity of FAE reaction did not associate with increases in the sIgE or SPT. We are not 
aware of any similar analyses of the longitudinal effects of unplanned accidental exposures 
among a cohort of children prospectively enrolled in an IRB-approved observational 
protocol in which allergen avoidance was advised. This observational study precluded the 
possibility of a matched control group that was followed without a food challenge that had 
passed a food challenge but was required not to ingest the food, or controls without any 
accidental exposure. Such a group cannot be identified from this cohort because there would 
be clinical differences between groups selected for OFCs, it would not be practical to 
prescribe avoidance after a subject passed an OFC in the context of this study, and it is 
always possible that accidental exposures occurred without obvious reactions, specifically in 
children already having become tolerant, which would invalidate comparisons with children 
who reacted. Therefore, we focused our analysis using participants as their own controls and 
did not observe meaningful increases in IgE or skin tests, the primary concern in clinical 
situations. As described in the Online Repository Supplemental Analyses, the trajectory of 
sIgE levels in the children having reactions paralleled the cohort as a whole. Nonetheless, 
having matched controls or a controlled trial of randomized exposures would have allowed 
analysis of any potential difference in natural course; such a study may also need to 
investigate any effects of pollen exposure on peanut tests.
Most data about the longitudinal effects of allergen exposures are derived from natural 
history studies of real-world populations attending clinics (11-19). In general, such studies 
are often performed at academic centers using retrospective chart review methods and tend 
to report on the relationship of IgE levels to allergen exposures in the context of planned 
OFCs (i.e. in children expected to be improving), rather than FAEs. Although these data 
carry with them important sources of bias including attrition and selection, and most 
participants are not challenged at study entry, they have nonetheless demonstrated that 
tolerance to foods is associated with falling IgE levels, a fact which is now well accepted 
(20). This finding has been replicated in an unselected, prospectively enrolled population-
based cohort in which participants underwent baseline and follow-up OFCs regardless of 
IgE level (21). While the persistence of food allergies (i.e., failing an OFC) was associated 
with higher allergen-specific IgE levels in essentially all of these studies, there is no 
Sicherer et al. Page 8
J Allergy Clin Immunol Pract. Author manuscript; available in PMC 2017 March 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
evidence from the studies involving serial OFCs (14, 16-19) that the levels were boosted by 
a failed challenge. It is important to note that prior to the establishment of predictive 
thresholds, there are subjects in some of these studies that failed annual OFCs for as many as 
ten years before resolving (19). Our study, in which failed OFCs resulted in clinically 
insignificant changes in IgE and SPT, further support the conclusion that such exposures do 
not worsen allergic sensitization among young children with egg, milk, and/or peanut 
allergy. We emphasize that we have evaluated the impact of single event oral exposures, in 
contrast to more persistent exposures that are known to increase specific IgE levels, for 
example during the pollen season or during oral immunotherapy. (6,7,22)”
The strengths of this study include its sampling of a large number of real-world clinical 
patients at multiple U.S. sites, years of longitudinal follow-up, and a uniform and 
protocolized approach to the collection of immunologic and extensive FAE data through a 
30-item questionnaire (4). These factors contribute to the validity of the study by facilitating 
comprehensive ascertainment of unplanned events and their sequelae.
We believe that the data presented here support the notion that occasional oral food allergen 
exposures, whether through accidents or planned food challenges, do not lead to enhanced 
sensitization that would delay resolution or otherwise worsen the long-term prognosis. If 
confirmed by other well-designed studies, these findings should provide a measure of 
comfort to both physicians and families as they deal with the aftermath of allergic reactions 
following food challenges or accidental exposures.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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What is already known about this topic?
Exposure to allergens, for example in the pollen seasons or during immunotherapy, can 
result in increases in specific IgE, but it is not known whether one-time exposures to food 
allergen ingestion meaningfully alter IgE levels.
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What does this article add to our knowledge?
Accidental or food challenge exposure to milk, egg or peanut that resulted in allergic 
reactions in children were not associated with significant increases in skin test size or 
allergen-specific IgE levels.
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How does this study impact current management guidelines?
The results suggest that oral food challenges should not be deferred due to concerns that 
reactions could affect prognosis.
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Figure 1. 
Median change in sIgE concentrations and SPT wheal size following reactions during OFCs. 
Panel 1a depicts change in sIgE. Median milk-specific IgE decreased by 0.10 kUA/L 
(p=0.13), egg-specific IgE decreased by 0.01 kUA/L (p=0.69) and no change for peanut 
(p=0.60). Panel 1b depicts change in SPT. No changes in SPT size were observed. The box 
encompasses quartiles 1-3, the line across the box marks the median and the diamond marks 
the mean. Circles are values more extreme than 1.5 times outside the interquartile range. P 
values <0.01 were considered statistically significant.
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Figure 2. 
Median change in sIgE concentration and SPT wheal size following FAEs. Panel 2a depicts 
change in sIgE. Median milk-specific IgE decreased by 0.33 kUA/L (p<.01), egg-specific 
IgE decreased by 0.34 kUA/L (p<0.01) and peanut-specific IgE increased by 0.13 kUA/L 
(p=0.03). Panel 2b depicts change in SPT. No change in SPT size was observed for milk. 
Egg SPT decreased by 1.0 mm (p=0.09) and peanut SPT increased by 1.5 mm (p=0.02). The 
box encompasses quartiles 1-3, the line across the box marks the median and the diamond 
marks the mean. Circles are values more extreme than 1.5 times outside the interquartile 
range. P values <0.01 were considered statistically significant.
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Table 1
Food-specific IgE and SPT results for positive and negative OFCs.
Food/Test Oral food
challenge
result
N Median value
pre/post
Median
change
p-value
Milk IgE Positive
Negative
26
56
0.66/0.42 kUA/L
0.34/0.27 kUA/L
−0.10 kUA/L
−0.00 kUA/L
0.13
0.11
Milk SPT Positive
Negative
27
56
5.00/6.00 mm
3.00/0.00 mm
0.50 mm
−2.50 mm
0.80
P<.01
Egg IgE Positive
Negative
22
64
0.70/1.30 kUA/L
0.25/0.21 kUA/L
−.01 kUA/L
−.02 kUA/L
0.69
0.32
Egg SPT Positive
Negative
22
61
6.50/6.50 mm
2.50/0.00 mm
−1.25 mm
−0.50 mm
0.37
P<.01
Peanut IgE Positive
Negative
22
39
1.20/2.00 kUA/L
0.14/0.12 kUA/L
−0.00 kUA/L
−0.01 kUA/L
0.60
0.54
Peanut SPT Positive
Negative
20
39
9.50/9.75 mm
0.00/0.00 mm
−1.25 mm
0.00 mm
0.96
0.14
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Table 2
Results limiting window of time between FAE and post-exposure testing to 12, 6, or 1 months
Food/Test
type
Time from
event
N Median value
pre/post
Median change p-value
Milk/IgE Within 12
months
205 5.21/4.14
kUA/L
−0.33 kUA/L −p<.01
Within 6
months
174 5.00/3.86
kUA/L
−0.33 kUA/L 0.022
Within 1
month
46 2.31/2.14
kUA/L
−0.22 kUA/L 0.215
Milk/SPT Within 12
months
207 9.00/10.00 mm 0.00 mm 0.547
Within 6
months
182 8.50/9.50 mm 0.00 mm 0.432
Within 1
month
44 8.00/9.50 mm 0.00 mm 0.953
Egg/IgE Within 12
months
156 4.18/3.31
kUA/L
−0.34 kUA/L p<.01
Within 6
months
122 3.46/3.29
kUA/L
−0.32 kUA/L 0.064
Within 1
month
31 5.97/3.72
kUA/L
−0.33 kUA/L 0.408
Egg/SPT Within 12
months
161 8.50/8.50 mm −1.00 mm 0.092
Within 6
months
129 8.50/9.00 mm −1.00 mm 0.120
Within 1
month
34 7.25/10.50 mm 0.25 mm 0.545
Peanut/IgE Within 12
months
85 7.44/8.33
kUA/L
0.13 kUA/L 0.029
Within 6
months
57 8.45/9.29
kUA/L
1.3 kUA/L 0.018
Within 1
month
7 2.29/5.60
kUA/L
1.3 kUA/L --
Peanut/SPT Within 12
months
85 10.00/10.00
mm
1.50 mm 0.022
Within 6
months
54 10.00/10.50
mm
1.75 mm p<.01
Within 1
month
8 10.25/17.25
mm
4.75 mm 0.047
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